Wedbush Equities Analysts Boost Earnings Estimates for Geron
Geron Co. (NASDAQ:GERN – Free Report) – Stock analysts at Wedbush upped their Q2 2025 earnings estimates for shares of Geron in a research report issued to clients and investors on Wednesday, February 26th. Wedbush analyst R. Driscoll now anticipates that the biopharmaceutical company will earn ($0.03) per share for the quarter, up from their […]
Geron Co. (NASDAQ:GERN – Free Report) – Stock analysts at Wedbush upped their Q2 2025 earnings estimates for shares of Geron in a research report issued to clients and investors on Wednesday, February 26th. Wedbush analyst R. Driscoll now anticipates that the biopharmaceutical company will earn ($0.03) per share for the quarter, up from their […]
